Literature DB >> 14690318

The role of chemotherapy in the management of carcinoma of the cervix.

Tate Thigpen1.   

Abstract

Carcinoma of the cervix remains the most common form of cancer to affect women worldwide despite effective screening techniques. Advances in treatment, particularly systemic therapies, have improved outcomes for cervical cancer. This article examines the role of chemotherapy, particularly in those patients with disseminated disease and those with locally advanced disease in the pelvis.

Entities:  

Mesh：

Year:  2003        PMID： 14690318     DOI： 10.1097/00130404-200309000-00013

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


  12 in total

1.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

2.  Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus.

Authors:  Laura M Ensign; Benjamin C Tang; Ying-Ying Wang; Terence A Tse; Timothy Hoen; Richard Cone; Justin Hanes
Journal:  Sci Transl Med       Date:  2012-06-13       Impact factor: 17.956

3.  Factors affecting platinum sensitivity in cervical cancer.

Authors:  Rina Kato; Kiyoshi Hasegawa; Yutaka Torii; Yasuhiro Udagawa; Ichio Fukasawa
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

4.  Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer.

Authors:  Tatsuru Ohara; Yoichi Kobayashi; Ayako Yoshida; Norihito Yoshioka; Namiko Yahagi; Haruhiro Kondo; Akiko Tozawa; Kazushige Kiguchi; Nao Suzuki
Journal:  Int J Clin Oncol       Date:  2012-10-25       Impact factor: 3.402

5.  12-Deacetyl-12-epi-Scalaradial, a Scalarane Sesterterpenoid from a Marine Sponge Hippospongia sp., Induces HeLa Cells Apoptosis via MAPK/ERK Pathway and Modulates Nuclear Receptor Nur77.

Authors:  Mi Zhou; Bo-Rong Peng; Wenjing Tian; Jui-Hsin Su; Guanghui Wang; Ting Lin; Dequan Zeng; Jyh-Horng Sheu; Haifeng Chen
Journal:  Mar Drugs       Date:  2020-07-21       Impact factor: 5.118

6.  Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.

Authors:  Kenta Masuda; Kouji Banno; Megumi Yanokura; Kosuke Tsuji; Yusuke Kobayashi; Iori Kisu; Arisa Ueki; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Rep       Date:  2012-07-13       Impact factor: 3.906

7.  The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study.

Authors:  Manabu Adachi; Mika Mizuno; Hiroko Mitsui; Hiroaki Kajiyama; Shiro Suzuki; Ryuichiro Sekiya; Fumi Utsumi; Kiyosumi Shibata; Tetsuo Taniguchi; Koji Kawaguchi; Kohei Yokoi; Fumitaka Kikkawa
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

8.  A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53.

Authors:  John Bechill; Rong Zhong; Chen Zhang; Elena Solomaha; Michael T Spiotto
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

9.  Chemotherapy and molecular targeting therapy for recurrent cervical cancer.

Authors:  Naotake Tsuda; Hidemichi Watari; Kimio Ushijima
Journal:  Chin J Cancer Res       Date:  2016-04       Impact factor: 5.087

10.  Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.

Authors:  Hisham A Abou-Taleb; Masafumi Koshiyama; Noriomi Matsumura; Tsukasa Baba; Ken Yamaguchi; Junzo Hamanishi; Kaoru Abiko; Koji Yamanoi; Ryusuke Murakami; Naoki Horikawa; Ahmed Aa Taha; Sachiko Kitamura; Ikuo Konishi
Journal:  J Int Med Res       Date:  2016-02-01       Impact factor: 1.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.